COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization

Nadia Nathan (1, 2) , Marie Legendre (1, 2) , Serge Amselem (1, 2) , Annick Clement (1, 2) , Emilie Filhol-Blin (1, 2) , Nicolas Richard , Sylvie Roullaud (3) , Michael Fayon (4, 5) , Gillian Rice (6) , Darragh Duffy (7) , Vincent Bondet (7) , Aurore Coulomb L’hermine (2) , Benedicte Neven (8, 9) , Marie-Louise Fremond (10) , Yanick Crow (10)

1 Physiopathologie des maladies génétiques d'expression pédiatrique
2 CHU Trousseau [APHP]
3 CH Angoulême - Centre Hospitalier d'Angoulême
4 CHU Bordeaux [Bordeaux]
5 CIC Bordeaux
6 University of Manchester [Manchester]
7 Immunobiologie des Cellules dendritiques
8 Département d'Immunologie, hématologie et rhumatologie pédiatriques [Hôpital Necker-Enfants malades - APHP]
9 Equipe Inserm U1163 - Immunogenetics of pediatric autoimmune diseases
10 Equipe Inserm U1163 - Laboratory of neurogenetics and neuroinflammation

Domains: Life Sciences [q-bio]

Nadia Nathan, Marie Legendre, Serge Amselem, Annick Clement, Emilie Filhol-Blin, et al.. COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization. ERS International Congress 2018 abstracts, Sep 2018, PARIS, France. pp.PA2236, ⟨10.1183/13993003.congress-2018.PA2236⟩. ⟨pasteur-03251889⟩